WT NFAT2 Citations (11)

Originally described in: NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription.
Monticelli S, Rao A Eur J Immunol. 2002 Oct . 32(10):2971-8. PubMed Journal

---

Articles Citing WT NFAT2

Articles
Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy. Cowling BS, McGrath MJ, Nguyen MA, Cottle DL, Kee AJ, Brown S, Schessl J, Zou Y, Joya J, Bonnemann CG, Hardeman EC, Mitchell CA. J Cell Biol. 2008 Dec 15;183(6):1033-48. doi: 10.1083/jcb.200804077. PubMed
Mitochondrial Ca2+ cycling facilitates activation of the transcription factor NFAT in sensory neurons. Kim MS, Usachev YM. J Neurosci. 2009 Sep 30;29(39):12101-14. doi: 10.1523/JNEUROSCI.3384-09.2009. PubMed
Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Muruganandan S, Dranse HJ, Rourke JL, McMullen NM, Sinal CJ. Stem Cells. 2013 Oct;31(10):2172-82. doi: 10.1002/stem.1450. PubMed
Murine gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cells. Rangaswamy US, Speck SH. PLoS Pathog. 2014 Jan;10(1):e1003858. doi: 10.1371/journal.ppat.1003858. Epub 2014 Jan 2. PubMed
FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation. Wilding BR, McGrath MJ, Bonne G, Mitchell CA. J Cell Sci. 2014 May 15;127(Pt 10):2269-81. doi: 10.1242/jcs.140905. Epub 2014 Mar 14. PubMed
Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer. Tripathi MK, Deane NG, Zhu J, An H, Mima S, Wang X, Padmanabhan S, Shi Z, Prodduturi N, Ciombor KK, Chen X, Washington MK, Zhang B, Beauchamp RD. Cancer Res. 2014 Dec 1;74(23):6947-57. doi: 10.1158/0008-5472.CAN-14-1592. Epub 2014 Oct 15. PubMed
TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion. Khan O, Giles JR, McDonald S, Manne S, Ngiow SF, Patel KP, Werner MT, Huang AC, Alexander KA, Wu JE, Attanasio J, Yan P, George SM, Bengsch B, Staupe RP, Donahue G, Xu W, Amaravadi RK, Xu X, Karakousis GC, Mitchell TC, Schuchter LM, Kaye J, Berger SL, Wherry EJ. Nature. 2019 Jul;571(7764):211-218. doi: 10.1038/s41586-019-1325-x. Epub 2019 Jun 17. PubMed
Targeting the DP2 receptor alleviates muscle atrophy and diet-induced obesity in mice through oxidative myofiber transition. Ning H, Ren H, Zhao Y, Yin H, Gan Z, Shen Y, Yu Y. J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):342-355. doi: 10.1002/jcsm.13136. Epub 2022 Dec 16. PubMed
AP-1-independent NFAT signaling maintains follicular T cell function in infection and autoimmunity. Seth A, Yokokura Y, Choi JY, Shyer JA, Vidyarthi A, Craft J. J Exp Med. 2023 May 1;220(5):e20211110. doi: 10.1084/jem.20211110. Epub 2023 Feb 23. PubMed
Long noncoding RNA Malat1 inhibits Tead3-Nfatc1-mediated osteoclastogenesis to suppress osteoporosis and bone metastasis. Zhao Y, Teng H, Deng Y, Sheldon M, Martinez C, Zhang J, Tian A, Sun Y, Nakagawa S, Yao F, Wang H, Ma L. Res Sq. 2023 Mar 20:rs.3.rs-2405644. doi: 10.21203/rs.3.rs-2405644/v1. Preprint. PubMed
Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis. Zhao Y, Ning J, Teng H, Deng Y, Sheldon M, Shi L, Martinez C, Zhang J, Tian A, Sun Y, Nakagawa S, Yao F, Wang H, Ma L. Nat Commun. 2024 Mar 16;15(1):2384. doi: 10.1038/s41467-024-46602-3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.